[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365142-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365142-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","in-silico-pan-cancer-analysis-of-vrac-subunits-and-their-prognostic-roles-in-human-cancers","In silico pan-cancer analysis of VRAC subunits and their prognostic roles in human cancers","","In silico pan-cancer analysis investigates the VRAC channel and the prognostic impact of its LRRC8 subunits across diverse tissues and cancers. Multi-omics bioinformatics integrates Human Protein Atlas and GTEx expression data, while linking LRRC8 mRNA variation to patient outcomes and incorporating DNA and RNA methylation analyses. Results associate LRRC8s with immune cell infiltration, cancer-associated fibroblasts, and immune regulators including MHCs and chemokines, suggesting roles in cancer signaling. Drug sensitivity analysis indicates differential effects on responses, supporting personalized therapeutic strategies and potential biomarker or target value in immunotherapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/in-silico-pan-cancer-analysis-of-vrac-subunits-and-their-prognostic-roles-in-human-cancers/365142/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/in-silico-pan-cancer-analysis-of-vrac-subunits-and-their-prognostic-roles-in-human-cancers/365142.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study on VRAC?","Question",{"text":63,"@type":64},"The study examines the VRAC channel and how its LRRC8 subunits contribute to cancer development and patient prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which datasets and analyses are integrated to study LRRC8 subunits?",{"text":68,"@type":64},"The work integrates mRNA expression data using Human Protein Atlas and GTEx, and includes analyses of DNA and RNA methylation alongside patient outcome associations.",{"name":70,"@type":61,"acceptedAnswer":71},"How are LRRC8 subunits related to the tumor immune microenvironment?",{"text":72,"@type":64},"The study reports significant correlations between LRRC8s expression and immune cell infiltration, with positive associations involving cancer-associated fibroblasts and immune regulators such as MHCs and chemokines.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365142,1790248923,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":113,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIn silico pan-cancer analysis of VRAC subunits and their prognostic roles in human cancers  \nAlessandro Paolì1,2, Soha Sadeghi1,2, Giulia Battistello1, Veronica Carpanese1 & Vanessa Checchetto1􀀍  \nThe study focuses on the VRAC channel and its significant roles in cancer development. It addresses a research gap by conducting a pan-cancer analysis with multi-omics bioinformatics tools, integrating data from the Human Protein Atlas (HPA) and Genotype-Tissue Expression (GTEx) datasets to examine mRNA expression patterns of its Leucine Rich Repeat Containing 8 (LRRC8) subunits in various tissues and cancers. The study links variations in LRRC8s expression with patient outcomesand includes analyses of DNA and RNA methylation. The study reveals significant correlations between LRRC8s expression and immune cell infiltration, as well as a positive association with cancerassociated fibroblasts and key immune regulators such as major histocompatibility complex (MHCs) and chemokines. Furthermore, the research suggests that LRRC8s are involved in cancer-signalling pathways, which may offer new therapeutic targets. Additionally, a drug sensitivity analysis shows that LRRC8 subunits affect drug responses differently, supporting the use of personalized therapeutic strategies. In conclusion, the study emphasizes the significance of VRAC subunits in cancer biology and suggests their potential as biomarkers and targets in cancer immunotherapy and personalized medicine.  \nKeywords VRAC, LRRC8 subunits, Immuno-oncology, Prognosis  \nAbbreviations  \nLRRC8 Leucine rich repeat containing 8  \nMAPK Mitogen-activated protein kinase  \nMCP-COUNTER Microenvironment cell populations-counter MHC Major histocompatibility complex  \nNF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells  \nNIK NF-Κb-inducing kinase  \nOS Overall survival  \nOV Ovarian cancer  \np53 Protein 53  \nPCPG Pheochromocytoma and paraganglioma  \nPI3K Phosphatidylinositol 3-kinase  \nPIP2 Phosphatidylinositol 4,5-bisphosphate  \nPIP5K1B Phosphatidylinositol-4-phosphate 5-kinase type 1 beta  \nPPI Protein–protein interaction  \nPt Platinum  \nRMBase Rna modification database  \nRNA-seq RNA-sequencing  \nROC Receiver-operating characteristic curve  \nRSEM RNA-seq by expectation maximization  \nRVD Regulatory volume decrease  \nSMART Shiny methylation analysis resource tool  \nSTING Stimulator of interferon genes  \nTCGA The cancer genome atlas  \nTIME Tumor immune microenvironment  \nTIMER Tumor immune estimation resource  \n1Department of Biology, University of Padova, Padua, Italy. 2Alessandro Paolì and Soha Sadeghi share first authorship. 􀀍 email: [vanessa.checchetto@unipd.it](vanessa.checchetto@unipd.it)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nTISIDB Tumor-immune system interactions and drug bank  \nTNF-α Tumor necrosis factor-alpha  \nTNM Tumor, node, metastasis  \nUALCAN University of Alabama at Birmingham Cancer data analysis portal  \nVRAC Volume regulated anion channel  \nCancer remains a leading cause of death globally, characterized by its rapid evolution and complexity, involving significant genetic and epigenetic changes1–3. These alterations lead to varied phenotypic and molecular manifestations of the disease, complicating its pathogenesis through complex interactions among multiple signalling pathways and genes. The increasing incidence of cancer is attributed to longer lifespans and changing risk factors, despite advances in various therapeutic approaches including surgery, chemoradiotherapy, targeted therapy, and immunotherapy. Unfortunately, the effectiveness of these treatments is often undermined by drug resistance and adverse reactions, underscoring the urgent need for novel pan-cancer biomarkers and therapeutic targets to improve patient outcomes4,5.  \nThe use of bioinformatics and extensive public cancer datasets presents a viable approach for investigating the m","cbCaiqqBl0jQFr0d","https://ap.wps.com/l/cbCaiqqBl0jQFr0d","pdf",14361800,"English","# Background\n## Cancer complexity and need for biomarkers\n## Bioinformatics and pan-cancer datasets\n## Ion channels in cancer biology\n# VRAC and chloride anion context\n## Chloride’s roles in cell functions\n## VRAC identification and characteristics\n# Prior evidence and research rationale","[{\"question\":\"What is the main focus of the study on VRAC?\",\"answer\":\"The study examines the VRAC channel and how its LRRC8 subunits contribute to cancer development and patient prognosis.\"},{\"question\":\"Which datasets and analyses are integrated to study LRRC8 subunits?\",\"answer\":\"The work integrates mRNA expression data using Human Protein Atlas and GTEx, and includes analyses of DNA and RNA methylation alongside patient outcome associations.\"},{\"question\":\"How are LRRC8 subunits related to the tumor immune microenvironment?\",\"answer\":\"The study reports significant correlations between LRRC8s expression and immune cell infiltration, with positive associations involving cancer-associated fibroblasts and immune regulators such as MHCs and chemokines.\"}]","In silico pan-cancer analysis of VRAC subunits and their prognostic roles in human cancers | PDF",1790160171,76,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6841f1164c7557813734a99d4e15cc4.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4df153638461af19810fb431a69f3c6f.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ac882cca922d54c7ff1ba5f26a8a1bd.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6845cad59224052ca06d1bdc67428aa3.webp",980,1287]